MediciNova (MNOV) Stock Rockets On Ibudilast Data

MediciNova MNOV Stock News

MediciNova, Inc. (NASDAQ: MNOV) is screaming for the top in the market this morning, gaining more than 30% before the bell after announcing the publication of positive results from a Phase 2 alcohol use disorder (AUD) clinical trial.  Here’s the scoop: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! MNOV … Read more

MannKind (MNKD) Stock Heads Up On NDA Acceptance

MannKind MNKD Stock News

MannKind Corporation (NASDAQ: MNKD) is headed up in the premarket hours this morning, and for good reason. The company announced that the FDA has accepted a New Drug Application for priority review. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! MNKD Heads Up On Priority Review Acceptance … Read more

AIM ImmunoTech (AIM) Stock Climbs On Ampligen Publication

AIM ImmunoTech AIM Stock News

AIM ImmunoTech Inc (NASDAQ: AIM) is headed for the top in the premarket hours this morning, and for good reason. The company announced that its flagship drug, Ampligen, has been featured in a peer-reviewed publication surrounding the treatment of cancer patients infected with the SARS-CoV-2 virus.  Here’s what’s happening: Stop wasting your time! Start finding … Read more

Novavax (NVAX) Stock Soars On Positive Vaccine Data

Novavax NVAX Stock News

Novavax, Inc (NASDAQ: NVAX) is screaming for the top in the premarket hours this morning after the company released positive data from a Phase 3 trial of its COVID-19 vaccine candidate. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! NVAX Climbs On COVID-19 News In the press … Read more

ChemoCentryx (CCXI) Stock Is Climbing: Here’s Why

ChemoCentrix CCXI Stock News

ChemoCentryx Inc (NASDAQ: CCXI) is screaming for the top in the market today, gaining momentum after yesterday’s more than 3% gains. The gains come after a massive decline in share values in May as investors see what could become a discounted opportunity to get in on future gains. However, there are major concerns to consider … Read more